Tag: volume

Milan, Italy – August 5, 2025 – Tensive S.r.l, a clinical-stage advanced biomaterials medical device company, and the developer of REGENERA™ and SOFTAG™ bioresorbable scaffolds for breast reconstruction and tissue marking, has appointed Bill Hunter, MD, as Chairman of its Board of Directors. Dr. Hunter brings more than 30 years of leadership in the medical technology and life sciences sectors. His appointment reflects Tensive’s focus on strengthening its governance and expanding its global network as it accelerates toward pivotal clinical milestones and commercialization in the U.S. and Europe.

Please see below information about transactions made under the third tranche of the 2025 share buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO).

Press Release

EfTEN United Property Fund's H1 2025 results were based on a fully invested portfolio. In addition, the property development investment in the fund's subsidiary Invego Uus-Järveküla OÜ has reached the stage where the completed terraced and semi-detached houses are being handed over to customers. Supported by the signing of real-right agreements at the Uus-Järveküla development, the fund's half-year profit increased more than fourfold compared to the same period of the previous year, and the fund made the historically largest cash distribution to investors, amounting to approximately 7% of the fund's market price.

Increased search volume around clean-label metabolic supplements — including queries like “ProZenith complaints” — reflects a wider shift in how consumers are navigating stimulant-free wellness solutions in North America.

More Americans Are Rethinking Collagen, Glucosamine, and Pills in 2025 as Public Curiosity Shifts Toward Ingredient-First Joint Hydration Formulas Like Simple Promises' XentaFlex